Tech Company Financing Transactions
Simcha Therapeutics Funding Round
Simcha Therapeutics, based in New Haven, scored $40 million from SR One Capital Management, ArrowMark Partners and BVF Partners.
Transaction Overview
Company Name
Announced On
2/4/2022
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
SR One Capital Management (Lead Investor) (Simeon George)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
504 Chapel St. 2nd Floor
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Undisclosed
Website
Email Address
Overview
Simcha Therapeutics is a biopharmaceutical company developing an engineered cytokine immunotherapy for cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Aaron Ring
Browse more venture capital transactions:
Prev: 2/4/2022: Zapp venture capital transaction
Next: 2/4/2022: StockGro venture capital transaction
Share this article
About Our VC Transactions Data
We record funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs